Search alternatives:
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
17661
A Systematic Review of Surface Contamination, Stability, and Disinfection Data on SARS-CoV‑2 (Through July 10, 2020)
Published 2020“…We conducted a systematic review of hygiene intervention effectiveness against SARS-CoV-2, including developing inclusion criteria, conducting the search, selecting articles for inclusion, and summarizing included articles. …”
-
17662
-
17663
-
17664
-
17665
-
17666
<i>In vitro</i> characterization of escape mutant viruses of anti-HA stalk antibody candidate clone F11.
Published 2021“…Although association of the G480D mutated virus (G6) decreased (ka [1/Ms] = 8.631 × 105), dissociation remained relatively low (kd (1/s) = 1.306 × 10–5) when compared with that for wild-type HA.…”
-
17667
-
17668
ShcA expression controls EMT-associated cell behavior.
Published 2015“…Error bars show standard error of the mean, based on three independent experiments. (E) Localization of diI-labeled NMuMG cells, either control cells or cells with decreased ShcA expression, in zebrafish, immediately after injection (0 dpi) or at day 3 after injection (3 dpi). …”
-
17669
-
17670
-
17671
-
17672
Age at treatment initiation–cross sex hormones.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
17673
Study characteristics.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
17674
Age at treatment initiation–puberty suppression.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
17675
Search terms.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
17676
PRISMA diagram.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
17677
PRISMA 2020 checklist.
Published 2023“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”
-
17678
-
17679
Data_Sheet_1_Blood Purification in Severe and Critical COVID-19 Patients: A Case Series of 5 Patients.docx
Published 2021“…</p><p>Results: Among the 5 patients, 4 were males ranging from 35 to 80 year old (Mean age = 63 ± 17.87). …”
-
17680